Read More Pharma Industry News Harpoon Therapeutics gets FDA fast track status for HPN217 in RRMM Harpoon Therapeutics has bagged fast track designation for HPN217 from the US Food and Drug Administration (FDA) for… bySrinathMarch 5, 2022